All financings
COMPANY TRANSACTIONS

Indaptus Therapeutics, Inc.

INDPNasdaqBiotechnology

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES

Deal notes

ContextDeal context

This is an ATM facility event. The capacity shown is not cash raised.

Gross proceedsNo cash proceeds
Offering price—
Discount to prior close—
Warrant coverage—

Transaction overview

01

Indaptus Therapeutics, Inc. disclosed an at-the-market program event: facility replaced. Authorized capacity is $100.0M. This event does not record cash proceeds raised.

Financing type
ATM
Announcement date
—
SEC disclosure date
Aug 31, 2026
Agreement date
Jun 1, 2022
Pricing date
—
Closing date
—
Filing date
Aug 31, 2026
Status
Amended
Market cap before SEC disclosure
$132.4M
Prior closing price
$1.14
Raise as % of market cap
—

Market data · FMP

Historical market cap
$132,389,582
Market date
Aug 28, 2026
Closing price
$1.14
Latest reported shares outstanding
113,242,000
Latest reported float shares
4,024,620
Share-data date
Oct 1, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 1, 2026.

Financial Modeling Prep ↗

Financing terms

02

At-the-market program

Capital event
Facility replaced
Authorized capacity
$100.0M
Proceeds raised
Not reported as raised
Shares sold
—
Average sale price
—
Relevant period
Not applicable
Sales commission
3%

Fees & transaction economics

03
Placement agent / underwriting fee
3%
Agent fee amount
—
Management fee
—
Other offering expenses (estimated)
—
Net proceeds (estimated)
—
Net proceeds as % of gross
—

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

424B5 · Indaptus Therapeutics, Inc.SEC filing · Aug 31, 2026
Open source ↗
FMP historical market data · INDPMarket data · Aug 28, 2026
Open source ↗
424B5 · Indaptus Therapeutics, Inc.SEC filing · Sep 4, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.